Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Persona™ Completes Series A1 Financing and Secures Long-Term Debt Facility

Posted on: 03 Dec 18
Persona™ Completes Series A1 Financing and Secures Long-Term Debt Facility Funding Round, led by Emil Capital and L Catterton's Growth Fund, will Fuel the Personalized Nutrition Startup's Rapid Expansion

PR Newswire

SEATTLE, Dec. 3, 2018

SEATTLE, Dec. 3, 2018 /PRNewswire/ -- Persona™, the leading personalized vitamin program, today announced it has closed its Series A1 financing. The funding round was led by Emil Capital, a leading private investment company with decades of retail investing experience focused on the American consumer, and the Growth Fund of L Catterton, the largest and most global consumer-focused private equity firm in the world, and an existing Persona investor. Persona will use the new funding to fuel the company's rapid expansion.

In addition, Persona announced a partnership with Silicon Valley Bank, which has provided a long-term debt facility to provide scalable banking solutions to support the company's rapid growth.

"We pride ourselves in identifying high-potential businesses that deliver exceptional experiences to customers and are excited to invest in Persona's personalized nutrition program as it embodies the foundation of our business and expectations of today's consumer," said Andreas Guldin, Founding Partner and CEO of Emil Capital.

Persona will use the new funding to support the company's production expansion and accelerate product development with an estimated 40 new proprietary dietary supplements in the works, including a new turmeric plus omega-3 all-in-one supplement and a time-released sleep support program.

"We are excited to receive new funding from Emil Capital and additional financial support from L Catterton. Emil Capital and L Catterton are two well-respected and admired financial and operational partners and we look forward to working together as we grow and expand the business," said Jason Brown, Founder and CEO of Persona. "We have built a business from a figment of my imagination into a flourishing program, delivering personalized nutrition to health-conscious consumers in all 50 states within our first 12 months of ecommerce. Persona's success is a result of the dedication and confidence of our medical advisory board, investors and team. Our customers are looking for valid customized nutritional products that are built on science, safety and a commitment to ongoing personalized wellness support."

For more information about Persona or to get started with a free nutritional assessment, please visit

About Persona
Persona™ combines therapeutic levels of nutritional support and a uniquely personalized vitamin program to deliver customized nutrition to subscribers' doorsteps. Based on science and using the highest-quality bioavailable ingredients, Persona's online assessment is built from its proprietary algorithm, which factors individual needs, lifestyle and prescription medications to deliver a recommendation as unique as you, and a convenient solution you can trust. Persona is founded by CEO Jason Brown, CNO Tamara Bernadot and CTO Prem Thudia, who have worked together for more than 20 years in the health care and supplement industries, exploring ways to bring better quality and personalized nutrition to the market. Giving back is at the heart of the company. As proud supporters of Vitamin Angels®, every Persona order provides at least two children who are at-risk of malnutrition a full year of vitamins, reducing preventable illness, blindness and death worldwide. To learn more, visit


View original content to download multimedia:

SOURCE Persona

PR Newswire

Last updated on: 03/12/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.